PET imaging is the most powerful and least invasive way of diagnosing and monitoring many cancers and unlike CT or MRI scans, it can measure cellular activity and metabolic changes in organs or tissues. Combining both PET/ CT or PET/MRI provides essential information by giving a full three-dimensional view of a body part and the location of cancer within it. Yet only one-third of the world population has access to PET imaging and all its capabilities.
Our ambition is to help medical and research centers gain access to PET imaging, by providing an unprecedented solution to current limitations imposed by the radiopharmaceutical production and distribution model of today. iMiGiNE relocates the production close to the patient and helps expand the spectrum of possibilities in the fields of medical diagnostics and biological research.
With iMiGiNE, personalized molecular imaging becomes a reality